← Back
F 10b5-1 Plan

$ Value

$43K

Shares

1,541

Price

$28

Filed

Feb 10

Insider

Name

Farquhar John C.M.

Title

Chief Executive Officer

CIK

0001900415

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-06

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

430,368

Footnotes

Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported. | Represents restricted stock units ("RSUs"), with a vesting commencement date of February 6, 2026 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. | The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. | This transaction was executed in multiple trades at price ranging from $26.74 to $29.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date

Filing Info

Accession No.

0001464521-26-000014

Form Type

4

Issuer CIK

0001464521

Farquhar John C.M.'s History

Date Ticker Type Value
2026-04-10 HTFL $603K
2026-03-18 HTFL $243K
2026-03-10 HTFL $291K
2026-03-06 HTFL A $42K
2026-02-10 HTFL $620K
2026-02-06 HTFL F $43K
2026-02-06 HTFL A $0
2026-02-06 HTFL A $0
2025-11-07 HTFL F $44K
2025-08-07 HTFL A $0

Other Insiders at HTFL (90d)

Insider Bought Sold Last
BARABE TIMOTHY C 2026-03-11
HealthCor Partners Management LP 2026-03-24
Lightcap Jeffrey C 2026-03-24
Rogers Campbell
Chief Medical Officer
$4.8M 2026-04-01
Bain Capital Life Sciences Investors, LLC $56.1M 2026-02-04
Cullivan Julie A $447K 2026-03-05
Farquhar John C.M.
Chief Executive Officer
$1.8M 2026-04-10
Jones Marie L.
Chief Accounting Officer, VP
2026-02-06
Verghese Vikram
Chief Financial Officer
2026-02-06